Bridging gaps at NLSDays 2021
We participated in the first digital NLSDays this week.
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 276 entries.
We participated in the first digital NLSDays this week.
Radforsk Investment Foundation has granted five research projects a total amount of NOK 4,95 million to further develop exciting research projects within photodynamic treatment and photochemical internalization. Cancer researcher Pål Selbo receives NOK 3,75 million for his project. Radforsk Investment Foundation is an evergreen investor focusing on companies that develop cancer treatment. “Radforsk has invested […]
Oslo Cancer Cluster har uttalt seg om Perspektivmeldingen 2021.
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway (UiT).
Oslo Cancer Cluster Innovation Park opened in May 2015.
The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.
Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.